BCM
Burrage Capital Management Portfolio holdings
AUM
$99.7M
This Quarter Return
+11.84%
1 Year Return
+65.92%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$122M
AUM Growth
+$122M
(-6.6%)
Cap. Flow
-$8.26M
Cap. Flow
% of AUM
-6.75%
Top 10 Holdings %
Top 10 Hldgs %
57.53%
Holding
30
New
5
Increased
5
Reduced
13
Closed
5
Top Buys
| 1 |
ESSA Pharma
EPIX
|
$6.9M |
| 2 |
Harmony Biosciences
HRMY
|
$4.96M |
| 3 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$3.91M |
| 4 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$3.49M |
| 5 |
Geron
GERN
|
$3.02M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$9.59M |
| 2 |
Insmed
INSM
|
$5.15M |
| 3 |
Aurinia Pharmaceuticals
AUPH
|
$4.65M |
| 4 |
Korro Bio
KRRO
|
$4.4M |
| 5 |
EPZM
Epizyme, Inc
EPZM
|
$3.19M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Protalix BioTherapeutics
PLX
$124M
| $9.48M | 7.68% |
2,125,585
-344,747
| -14% | -$1.54M |
|
2
BioCryst Pharmaceuticals
BCRX
$1.74B
| $8.8M | 7.13% |
864,916
-240,757
| -22% | -$2.45M |
|
3
MEI Pharma
MEIP
$160M
| $8M | 6.48% |
2,331,313
-874,625
| -27% | -$3M |
|
4
PTC Therapeutics
PTCT
$3.92B
| $7.59M | 6.15% |
160,372
-711
| -0.4% | -$33.7K |
|
5
NeoGenomics
NEO
$1.13B
| $7.13M | 5.78% |
147,921
-30,856
| -17% | -$1.49M |
|
|
6
ESSA Pharma
EPIX
$11.4M
| $6.9M | 5.59% |
+237,442
| New | +$6.9M |
|
|
TPTX
7
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $6.83M | 5.53% |
72,164
-320
| -0.4% | -$30.3K |
|
8
Cytokinetics
CYTK
$4.23B
| $5.69M | 4.61% |
244,673
-1,363
| -0.6% | -$31.7K |
|
9
Intellia Therapeutics
NTLA
$1.22B
| $5.11M | 4.14% |
63,634
-445
| -0.7% | -$35.7K |
|
|
10
Harmony Biosciences
HRMY
$2.12B
| $4.96M | 4.02% |
+150,000
| New | +$4.96M |
|
|
EPZM
11
DELISTED
Epizyme, Inc
EPZM
| $4.92M | 3.98% |
564,555
-365,912
| -39% | -$3.19M |
|
12
Crinetics Pharmaceuticals
CRNX
$2.92B
| $4.16M | 3.37% |
272,393
+48,264
| +22% | +$737K |
|
13
Mirum Pharmaceuticals
MIRM
$3.71B
| $4.08M | 3.31% |
205,866
+44,238
| +27% | +$877K |
|
|
TVRD
14
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $3.91M | 3.17% |
+180,000
| New | +$3.91M |
|
15
Fulcrum Therapeutics
FULC
$351M
| $3.77M | 3.05% |
319,819
+47,893
| +18% | +$564K |
|
|
TCDA
16
DELISTED
Tricida, Inc. Common Stock
TCDA
| $3.49M | 2.82% |
+658,877
| New | +$3.49M |
|
17
Apellis Pharmaceuticals
APLS
$3.48B
| $3.46M | 2.81% |
80,727
-630
| -0.8% | -$27K |
|
18
Y-mAbs Therapeutics
YMAB
$388M
| $3.46M | 2.8% |
114,454
-508
| -0.4% | -$15.4K |
|
|
INZY
19
DELISTED
Inozyme Pharma
INZY
| $3.36M | 2.72% |
169,473
-1,323
| -0.8% | -$26.2K |
|
|
TECX
20
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $3.11M | 2.52% |
244,920
+99,205
| +68% | +$1.26M |
|
21
ADC Therapeutics
ADCT
$345M
| $3.05M | 2.47% |
124,875
-975
| -0.8% | -$23.8K |
|
|
22
Geron
GERN
$893M
| $3.02M | 2.45% |
+1,912,673
| New | +$3.02M |
|
|
GTHX
23
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.83M | 2.29% |
117,708
| – | – |
|
24
Merus
MRUS
$4.98B
| $2.73M | 2.21% |
130,683
| – | – |
|
25
Black Diamond Therapeutics
BDTX
$157M
| $2.68M | 2.17% |
110,447
+75,556
| +217% | +$1.83M |
|